New Therapy to Remove Cholesterol

What is LDL Apheresis?

LDL apheresis is a procedure that selectively removes harmful Low Density Lipoprotein (LDL) from the bloodstream and returns the other blood components (blood cells, proteins, antibodies, and HDL) back to the body. Emory is the only Georgia facility to provide this procedure.

This procedure has been shown to be proven, effective, safe, and unique. It is very well tolerated has been demonstrated to lower LDL-C 73-83% after a single treatment while having minimal impact on other essential plasma components such as HDL-C and albumin. No other procedure has the flexibility to target a specific LDL-C treatment goal. In order to be eligible for the treatment, patients must first be on maximum medication and diet therapy for 6 months and meet the following criteria as specified by the FDA:

Approved by the FDA since 1996, there have been more than 25,000 treatments performed nation-wide. Medicare as well as most insurance policies covers the procedure, and complementary insurance consultation is available from the manufacturer to verify proper pre-authorization of coverage.

This Web site is provided as a courtesy to those interested in Emory Healthcare and does not constitute medical advice and does not create any physician/patient relationship. Also, Emory Healthcare does not endorse or recommend any specific commercial product or service. This Web site is provided solely for personal and private use of individuals accessing this information, and no part of it may be used for any other purpose.